(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)
BPC-157, GHK-Cu, and TB-500 are three of the most discussed peptides in regenerative medicine, sports recovery, aesthetics, and tissue repair
10.1111/bjd.20608 63 HartwigT.ZwickyP.SchreinerB.YawalkarN.ChengP.NavariniA.et al (2018)
There was a dose-finding trial done by Eussen et al
Other Services:
Medication Image Disclaimer The medication images displayed on this website are for general informational purposes only and do not represent the exact product, packaging, or labeling dispensed to patients